FlindulatinCAS# 521-44-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 521-44-8 | SDF | Download SDF |
PubChem ID | 5466138 | Appearance | Yellow powder |
Formula | C19H18O7 | M.Wt | 358.3 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5-hydroxy-3,7,8-trimethoxy-2-(4-methoxyphenyl)chromen-4-one | ||
SMILES | COC1=CC=C(C=C1)C2=C(C(=O)C3=C(O2)C(=C(C=C3O)OC)OC)OC | ||
Standard InChIKey | SQOMVBRIXCJFKW-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H18O7/c1-22-11-7-5-10(6-8-11)16-19(25-4)15(21)14-12(20)9-13(23-2)17(24-3)18(14)26-16/h5-9,20H,1-4H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Flindulatin Dilution Calculator
Flindulatin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.791 mL | 13.9548 mL | 27.9096 mL | 55.8191 mL | 69.7739 mL |
5 mM | 0.5582 mL | 2.791 mL | 5.5819 mL | 11.1638 mL | 13.9548 mL |
10 mM | 0.2791 mL | 1.3955 mL | 2.791 mL | 5.5819 mL | 6.9774 mL |
50 mM | 0.0558 mL | 0.2791 mL | 0.5582 mL | 1.1164 mL | 1.3955 mL |
100 mM | 0.0279 mL | 0.1395 mL | 0.2791 mL | 0.5582 mL | 0.6977 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Tabernaecorymbosine A
Catalog No.:BCN0464
CAS No.:1262306-81-9
- Alpinigenine
Catalog No.:BCN0463
CAS No.:14028-91-2
- 2,4-Dihydroxy-6-methoxy-3,5-diprenylacetophenone
Catalog No.:BCN0462
CAS No.:123999-38-2
- 4,5-Dioxodehydroasimilobine
Catalog No.:BCN0461
CAS No.:82644-81-3
- 3,8-Di-O-methylellagic acid 2-O-(5'-O-acetyl)arabinofuranoside
Catalog No.:BCN0460
CAS No.:365540-09-6
- 5-exo-Hydroxyborneol
Catalog No.:BCN0459
CAS No.:32751-73-8
- (+/-)-N-methylcoclaurine
Catalog No.:BCN0458
CAS No.:1472-62-4
- Bis(2-ethylhexyl) terephthalate
Catalog No.:BCN0457
CAS No.:6422-86-2
- Toxyloxanthone B
Catalog No.:BCN0456
CAS No.:50875-24-6
- V1 iridoid
Catalog No.:BCN0455
CAS No.:87441-71-2
- Acronyculatin Q
Catalog No.:BCN0454
CAS No.:2287183-54-2
- Mecambridine
Catalog No.:BCN0453
CAS No.:31098-60-9
- (±)-Cleroindicin F
Catalog No.:BCN0466
CAS No.:94535-01-0
- p-O-Farnesylcoumaric acid
Catalog No.:BCN0467
CAS No.:939769-47-8
- 6,4'-Dihydroxy-5,7-dimethoxyflavanone
Catalog No.:BCN0468
CAS No.:6951-57-1
- 5-endo-Hydroxyborneol
Catalog No.:BCN0469
CAS No.:68738-10-3
- 1-O-p-Coumaroylglucose
Catalog No.:BCN0470
CAS No.:7139-64-2
- 1-O-Cinnamoylglucose
Catalog No.:BCN0471
CAS No.:40004-96-4
- 1,4-Dihydro-1-methyl-4-oxonicotinamide
Catalog No.:BCN0472
CAS No.:769-49-3
- Acrotrione
Catalog No.:BCN0473
CAS No.:2349327-31-5
- Polypodine B 20,22-acetonide
Catalog No.:BCN0474
CAS No.:159858-85-2
- 2',3'-Dehydromarmesin
Catalog No.:BCN0475
CAS No.:28664-60-0
- (±)-8-Gingerol
Catalog No.:BCN0476
CAS No.:77398-92-6
- Ferruginoside C
Catalog No.:BCN0477
CAS No.:213991-03-8
Antifungal Quinoline Alkaloids from Waltheria indica.[Pubmed:26848627]
J Nat Prod. 2016 Feb 26;79(2):300-7.
Chemical investigation of a dichloromethane extract of the aerial parts of Waltheria indica led to the isolation and characterization of five polyhydroxymethoxyflavonoids, namely, oxyanin A (1), vitexicarpin (3), chrysosplenol E (4), Flindulatin (5), 5-hydroxy-3,7,4'-trimethoxyflavone (6), and six quinolone alkaloids, waltheriones M-Q (2, 7, 8, 10, 11) and 5(R)-vanessine (9). Among these, compounds 2, 7, 8, 10, and 11 have not yet been described in the literature. Their chemical structures were established by means of spectroscopic data interpretation including (1)H and (13)C, HSQC, HMBC, COSY, and NOESY NMR experiments and UV, IR, and HRESIMS. The absolute configurations of the compounds were established by ECD. The isolated constituents and 10 additional quinoline alkaloids previously isolated from the roots of the plant were evaluated for their in vitro antifungal activity against the human fungal pathogen Candida albicans, and 10 compounds (7, 9, 11-16, 18, 21) showed growth inhibitory activity on both planktonic cells and biofilms (MIC = 32 mug/mL). Their spectrum of activity against other pathogenic Candida species and their cytotoxicity against human HeLa cells were also determined. In addition, the cytological effect of the antifungal isolated compounds on the ultrastructure of C. albicans was evaluated by transmission electron microscopy.